Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021
Research

Mycoplasma genitalium and Other Reproductive Tract Infections in Pregnant Women, Papua New Guinea, 2015–2017

Michelle J.L. ScoullarComments to Author , Philippe Boeuf, Elizabeth Peach, Ruth Fidelis, Kerryanne Tokmun, Pele Melepia, Arthur Elijah, Catriona S. Bradshaw, Glenda Fehler, Peter M. Siba, Simon Erskine, Elisa Mokany, Elissa Kennedy, Alexandra J. Umbers, Stanley Luchters, Leanne J. Robinson, Nicholas C. Wong, Andrew J. Vallely, Steven G. Badman, Lisa M. Vallely, Freya J.I. Fowkes, Christopher Morgan, William Pomat, Brendan S. Crabb, James G. BeesonComments to Author , and Healthy Mothers Healthy Babies Study Team1
Author affiliations: Burnet Institute, Melbourne, Victoria, Australia (M.J.L. Scoullar, P. Boeuf, E. Peach, R. Fidelis, K. Tokmun, P. Melepia, E. Kennedy, A.J. Umbers, S. Luchters, L.J. Robinson, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); Burnet Institute, Kokopo, Papua New Guinea (M.J.L. Scoullar, P. Boeuf, E. Peach, R. Fidelis, K. Tokmun, P. Melepia, E. Kennedy, A.J. Umbers, S. Luchters, L.J. Robinson, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); University of Melbourne, Melbourne (M.J.L Scoullar, P. Boeuf, C.S. Bradshaw, L.J. Robinson, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); University of Papua New Guinea, Port Moresby, Papua New Guinea (A. Elijah); Melbourne Sexual Health Centre, Melbourne (C.S. Bradshaw, G. Fehler); Monash University, Melbourne (C.S. Bradshaw, S. Luchters, L.J. Robinson, N.C. Wong, F.J.I. Fowkes, C. Morgan, B.S. Crabb, J.G. Beeson); Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea (P.M. Siba, L.J. Robinson, A. Vallely, L.M. Vallely, W. Pomat); SpeeDx Pty Ltd, Sydney, New South Wales, Australia (S. Erskine, E. Mokany); Aga Khan University, Nairobi, Kenya (S. Luchters); Ghent University, Ghent, Belgium (S. Luchters); University of New South Wales, Sydney (A. Vallely, S.G. Badman, L.M. Vallely); James Cook University, Townsville, Queensland, Australia (L.M. Vallely)

Main Article

Table 4

Multivariable analysis of factors associated with current sexually transmitted infections in pregnant women, East New Britain, Papua New Guinea, 2015–2017*

Characteristic Sexually transmitted infection, aOR (95% CI); p value
Mycoplasma genitalium Chlamydia trachomatis Neisseria gonorrhoeae Trichomonas vaginalis >1 infection
Clinic
Vunapope Referent Referent Referent Referent Referent
Nonga 0.68 (0.28–1.62); 0.38 0.88 (0.43–1.78); 0.72 2.35 (0.76–7.32); 0.14 0.91 (0.42–1.97); 0.82 0.84 (0.43–1.63); 0.61
Kerevat 0.9 (0.43–1.88); 0.77 0.55 (0.28–1.09); 0.09 1.03 (0.3–3.5); 0.97 0.84 (0.41–1.72); 0.62 0.58 (0.31–1.11); 0.10
Napapar 0.76 (0.37–1.57); 0.46 0.9 (0.5–1.62); 0.73 0.99 (0.31–3.15); 0.98 1.09 (0.6–1.99); 0.77 0.64 (0.36–1.13); 0.12
Paparatava
 0.86 (0.43–1.73); 0.68
 0.86 (0.47–1.57); 0.62
 2.04 (0.7–5.95); 0.19
 1.08 (0.59–1.99); 0.79
 1.01 (0.58–1.75); 0.97
Age, y
>35 Referent Referent Referent Referent Referent
25–34 0.76 (0.34–1.69); 0.50 2.47 (0.94–6.52); 0.07 1.01 (0.2–4.98); 0.99 1.85 (0.78–4.37); 0.16 1.7 (0.85–3.38); 0.13
16–24
 1.21 (0.52–2.82); 0.66
 3.39 (1.24–9.28); 0.02
 1.86 (0.36–9.63); 0.46
 2.31 (0.93–5.7); 0.07
 2.45 (1.17–5.16); 0.02
Gravidity
Multigravida Referent Referent Referent Referent Referent
Primigravida
 0.87 (0.46–1.65); 0.67
 2.17 (1.29–3.64); <0.01
 4.33 (1.74–10.75); <0.01
 1.09 (0.62–1.92); 0.75
 1.45 (0.87–2.42); 0.15
Marital status
Married/cohabiting Referent Referent Referent Referent Referent
Single/separated
 1.06 (0.34–3.3); 0.92
 1.31 (0.54–3.13); 0.55
 0.44 (0.09–2.23); 0.32
 4.48 (1.9–10.55); <0.01
 1.6 (0.61–4.21); 0.34
Vaginal discharge
No symptoms Referent Referent Referent Referent Referent
Abnormal discharge (current or before first antenatal clinic)
 1.17 (0.63–2.15); 0.62
 1.29 (0.78–2.14); 0.33
 1.45 (0.6–3.53); 0.41
 1.56 (0.94–2.59); 0.09
 1.29 (0.79–2.11); 0.31
Has used modern contraception
Yes Referent Referent Referent Referent Referent
No
 1.82 (0.82–4.08); 0.14
 1.04 (0.56–1.95); 0.90
 0.77 (0.23–2.59); 0.67
 1.27 (0.66–2.43); 0.47
 1.17 (0.67–2.05); 0.57
Employment status
Unemployed Referent Referent Referent Referent Referent
Employed
 0.89 (0.49–1.62); 0.71
 1.27 (0.79–2.05); 0.32
 2.66 (1.24–5.71); 0.01
 0.96 (0.57–1.62); 0.89
 1.29 (0.81–2.06); 0.28
Urine nitrite
Trace 0.49 (0.11–2.12); 0.34 0.78 (0.25–2.43); 0.667 0.68 (0.08–5.55); 0.72 0.34 (0.07–1.61); 0.17 0.35 (0.11–1.11); 0.08
Positive
 1.32 (0.58–3); 0.50
 1.88 (0.94–3.74); 0.07
 1.6 (0.5–5.09); 0.43
 1.29 (0.6–2.76); 0.51
 1.26 (0.62–2.58); 0.53
Fever during pregnancy
No Referent Referent Referent Referent Referent
Yes (before first antenatal clinic) 1.15 (0.66–1.99); 0.63 0.75 (0.46–1.24); 0.26 0.69 (0.29–1.65); 0.41 1.58 (0.99–2.53); 0.05 1 (0.63–1.57); 0.99

*aOR, adjusted odds ratio.

Main Article

1Members of this group are listed at the end of this article.

Page created: January 11, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external